Literature DB >> 10426188

Conserved transactivation domain shared by interferon regulatory factors and Smad morphogens.

A Eroshkin1, A Mushegian.   

Abstract

Interferon regulatory factors (IRFs) regulate the transcription of both interferon-inducible genes and interferons themselves. Along with the N-terminal, DNA-binding, winged-helix domain, most IRFs contain the C-terminal domains that are shown to be related to the C-terminal domains in the proteins of the Smad family that mediate transcription activation in the transforming growth factor response pathway. Comparison of the IRF-Smad alignment to the known three-dimensional structure of human tumor suppressor Smad4 suggests that a conserved loop, equivalent to Loop 3 in Smad 4, is a determinant of protein-protein interaction in IRFs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426188     DOI: 10.1007/s001090050369

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  18 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 2.  IRF7: activation, regulation, modification and function.

Authors:  S Ning; J S Pagano; G N Barber
Journal:  Genes Immun       Date:  2011-04-14       Impact factor: 2.676

3.  Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain.

Authors:  Michelle M Arnold; Mario Barro; John T Patton
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

4.  A murrel interferon regulatory factor-1: molecular characterization, gene expression and cell protection activity.

Authors:  Jesu Arockiaraj; Akila Sathyamoorthi; Venkatesh Kumaresan; Rajesh Palanisamy; Mukesh Kumar Chaurasia; Prasanth Bhatt; Annie J Gnanam; Mukesh Pasupuleti; Abirami Arasu
Journal:  Mol Biol Rep       Date:  2014-05-24       Impact factor: 2.316

5.  Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Henry R Bose
Journal:  Mol Biol Evol       Date:  2009-07-28       Impact factor: 16.240

Review 6.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

7.  Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership.

Authors:  Caleb M Bailey; Zhila Khalkhali-Ellis; Shinji Kondo; Naira V Margaryan; Richard E B Seftor; William W Wheaton; Sumaira Amir; Michael R Pins; Brian C Schutte; Mary J C Hendrix
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

8.  Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.

Authors:  Minghua Wu; Brian Skaug; Xiongjie Bi; Tingting Mills; Gloria Salazar; Xiaodong Zhou; John Reveille; Sandeep K Agarwal; Michael R Blackburn; Maureen D Mayes; Shervin Assassi
Journal:  Ann Rheum Dis       Date:  2019-08-22       Impact factor: 19.103

9.  Novel mutations in the IRF6 gene for Van der Woude syndrome.

Authors:  Xiaofang Wang; Jiali Liu; Haibing Zhang; Mingzhen Xiao; Jinfeng Li; Chunling Yang; Xianjun Lin; Zizhong Wu; Landian Hu; Xiangyin Kong
Journal:  Hum Genet       Date:  2003-08-14       Impact factor: 4.132

10.  Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes.

Authors:  Shinji Kondo; Brian C Schutte; Rebecca J Richardson; Bryan C Bjork; Alexandra S Knight; Yoriko Watanabe; Emma Howard; Renata L L Ferreira de Lima; Sandra Daack-Hirsch; Achim Sander; Donna M McDonald-McGinn; Elaine H Zackai; Edward J Lammer; Arthur S Aylsworth; Holly H Ardinger; Andrew C Lidral; Barbara R Pober; Lina Moreno; Mauricio Arcos-Burgos; Consuelo Valencia; Claude Houdayer; Michel Bahuau; Danilo Moretti-Ferreira; Antonio Richieri-Costa; Michael J Dixon; Jeffrey C Murray
Journal:  Nat Genet       Date:  2002-09-03       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.